| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |